Behnood Bikdeli MD, MS
Associate Physician, Section of Vascular Medicine, Cardiovascular Medicine Division, Brigham and Women’s Hospital; Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts; Investigator, YNHH/ Yale Center for Outcomes Research and Evaluation (CORE), New Haven, ConnecticutBehnood Bikdeli, MD, MS, is a clinician-investigator, with training in cardiology and in vascular medicine who is particularly interested in thrombotic diseases.
He is an Associate Physician in the Division of Cardiovascular Medicine at Brigham and Women’s Hospital, an Instructor in Medicine at Harvard Medical School, and an investigator at Yale Center for Outcomes Research and Evaluation (CORE).
His research has been funded by the NIH, the American Heart Association, Brigham and Women’s Hospital and others.
He has coauthored more than 180 publications, which have been published in journals including Lancet, JAMA, JAMA Internal Medicine, Circulation, Journal of the American College of Cardiology, the British Medical Journal, and others.
Dr. Bikdeli was the lead author of two international consensus documents related to thrombosis in COVID-19, is the joint principal investigator of the INSPIRATION/ INSPIRATION-S randomized controlled trial, and is an Associate Editor for Thrombosis Research.
Disclosures
Dr. Bikdeli was the senior investigator for the summarized study. He did not receive research funding or consulting fees for the above-mentioned summary, although the project itself was support by the Medicines Company and the Cardiovascular Research Foundation (CRF).
Outside the submitted summary, Dr. Bikdeli is supported by a Career Development Award from the American Heart Association and VIVA Physicians (#938814). Dr. Bikdeli was supported by the Scott Schoen and Nancy Adams IGNITE Award and is supported by the Mary Ann Tynan Research Scientist award from the Mary Horrigan Connors Center for Women’s Health and Gender Biology at Brigham and Women’s Hospital, and the Heart and Vascular Center Junior Faculty Award from Brigham and Women’s Hospital. Dr. Bikdeli reports that he was a consulting expert, on behalf of the plaintiff, for litigation related to two specific brand models of IVC filters. Dr. Bikdeli has not been involved in the litigation in 2022-2024 nor has he received any compensation in 2022-2024. Dr. Bikdeli reports that he is a member of the Medical Advisory Board for the North American Thrombosis Forum, and serves in the Data Safety and Monitory Board of the NAIL-IT trial funded by the National Heart, Lung, and Blood Institute, and Translational Sciences. Dr. Bikdeli is a collaborating consultant with the International Consulting Associates and the US Food and Drug Administration in a study to generate knowledge about utilization, predictors, retrieval, and safety of IVC filters. Dr. Bikdeli receives compensation as an Associate Editor for the New England Journal of Medicine Journal Watch Cardiology, as an Associate Editor for Thrombosis Research, and as an Executive Associate Editor for JACC, and is a Section Editor for Thrombosis and Haemostasis (no compensation).